These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 15450742)

  • 21. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection.
    Morizono K; Xie Y; Ringpis GE; Johnson M; Nassanian H; Lee B; Wu L; Chen IS
    Nat Med; 2005 Mar; 11(3):346-52. PubMed ID: 15711560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninfectious gene transfer and expression systems for cancer gene therapy.
    Cooper MJ
    Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
    Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
    Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alphavirus vectors for cancer gene therapy (review).
    Yamanaka R
    Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo antitumor activity of Sindbis viral vectors.
    Tseng JC; Levin B; Hirano T; Yee H; Pampeno C; Meruelo D
    J Natl Cancer Inst; 2002 Dec; 94(23):1790-802. PubMed ID: 12464651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy that safely targets and kills tumor cells throughout the body.
    Hurtado A; Tseng JC; Meruelo D
    Rejuvenation Res; 2006; 9(1):36-44. PubMed ID: 16608394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses.
    Olivo PD; Frolov I; Schlesinger S
    Virology; 1994 Jan; 198(1):381-4. PubMed ID: 8259675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral delivery for gene therapy against cell movement in cancer.
    Wu TL; Zhou D
    Adv Drug Deliv Rev; 2011 Jul; 63(8):671-7. PubMed ID: 21616108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
    Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
    Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer gene-therapy: clinical trials.
    Palmer DH; Young LS; Mautner V
    Trends Biotechnol; 2006 Feb; 24(2):76-82. PubMed ID: 16380178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity.
    Cheng WF; Lee CN; Su YN; Chai CY; Chang MC; Polo JM; Hung CF; Wu TC; Hsieh CY; Chen CA
    Cancer Gene Ther; 2006 Sep; 13(9):873-85. PubMed ID: 16645621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral and non-viral vectors for cancer gene therapy.
    Cristiano RJ
    Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
    He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
    Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral vectors: systemic delivery and tumor targeting.
    Green NK; Seymour LW
    Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic herpes simplex virus vectors for cancer virotherapy.
    Varghese S; Rabkin SD
    Cancer Gene Ther; 2002 Dec; 9(12):967-78. PubMed ID: 12522436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope.
    Morizono K; Ringpis GE; Pariente N; Xie Y; Chen IS
    Virology; 2006 Nov; 355(1):71-81. PubMed ID: 16905172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alphavirus DNA and particle replicons for vaccines and gene therapy.
    Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
    Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting strategies in cancer gene therapy.
    Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.